On 8 July, Leem, the professional body for pharmaceutical companies in France, concluded its first sector-wide agreement with the CFE-CGC, CFTC, FO and Unsa unions on the integration and retention of older workers. Extending the scope of mandatory talks set out in the July 2025 law on the employment of experienced staff, the deal will take effect on 1 January 2026 for three years.
Publication
15 September 2025 à 09h51
Updated on 18 September 2025 à 11h38
Publication:
15 September 2025 à 09h51, Updated on 18 September 2025 à 11h38
Reading time:
6 minutes
Enjoy this article for free while you’re in your trial period
You have access to our content for 1 month.
Reflecting the longer careers brought about by France’s decision to raise the retirement age from 62 to 64, Leem — which represents 280 pharmaceutical companies spanning research, production and distribution — signed its first agreement with trade unions on 8 September. This agreement also reflects the industry’s desire to join the movement launched by the government in favour of ‘experienced’ workers in May. To this end, the social partners are inviting companies in the pharmaceutical sector to put in place a policy supporting older employees as part of an approach to managing jobs and career paths (GEPP). “It will be up to companies to define and offer a secure framework for senior employees, while taking a more global approach to career management,” states the text.
You are reading this article thanks to your trial period.
Explore new horizons by checking out our other verticals:
You are reading this article thanks to your subscription to Mind Retail.
Explore new horizons by checking out our other verticals:
